ACHN
Achillion Pharmaceuticals, Inc.
ACHN
ACHN
Delisted
ACHN was delisted on the 27th of January, 2020.
179 hedge funds and large institutions have $1.08B invested in Achillion Pharmaceuticals, Inc. in 2014 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 53 increasing their positions, 58 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
179
Holders Change
+18
Holders Change %
+11.18%
% of All Funds
4.78%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.13%
New
48
Increased
53
Reduced
58
Closed
26
Calls
$126M
Puts
$64.1M
Net Calls
+$61.4M
Net Calls Change
-$24.5M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$52.8M |
| 2 |
DM
Deerfield Management
New York
|
+$35.8M |
| 3 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$29.1M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$25.4M |
| 5 |
Goldman Sachs
New York
|
+$20.2M |
Top Sellers
| 1 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$32.4M |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$30.4M |
| 3 |
QF
QVT Financial
New York
|
-$24.4M |
| 4 |
Renaissance Technologies
New York
|
-$8.96M |
| 5 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$6.23M |
